Back to companies
TScan Therapeutics, Inc.
TCRXUSNASDAQPharmaceuticals & HealthcareTScan Therapeutics, Inc.
Revenue
$10.3mn
YoY +266.7%
Operating income
-$135.8mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API